10:29 AM EST, 12/13/2024 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) filed a registration statement Friday with the US Securities and Exchange Commission for the potential sale of up to $300 million of its securities via one or more offerings.

The registration covers common stock, preferred stock, debt securities, warrants, subscription rights, purchase contracts, and units, according to the filing.

The company said it will outline how it plans to use the proceeds from the sale of securities in a prospectus supplement.

Price: 7.12, Change: -0.01, Percent Change: -0.14